CAR- T and also cellular gene therapies are also expensive

.Mother Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and technology move can easily provide mobile gene therapies at a cost effective expense to patients across the planet.